Alkermes plc. Interest Expense
Alkermes plc. (ALKS) reported Interest Expense of $5.95 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-07-24.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-07-24
- Alkermes plc. interest expense for the quarter ending 2024-06-30 was $5.95M, a 4.71% increase year-over-year.
- Alkermes plc. interest expense for the quarter ending 2024-03-31 was $5.98M, a 13.05% increase year-over-year.
- Alkermes plc. interest expense for the quarter ending 2023-12-31 was $6.05M, a 26.94% increase year-over-year.
- Alkermes plc. interest expense for the quarter ending 2023-09-30 was $6.01M, a 69.09% increase year-over-year.
- Alkermes plc. interest expense for fiscal 2023 was $23.03M, a 76.63% increase from fiscal 2022.
- Alkermes plc. interest expense for fiscal 2022 was $13.04M, a 16.23% increase from fiscal 2021.
- Alkermes plc. interest expense for fiscal 2021 was $11.22M, a 29.56% increase from fiscal 2020.
- Alkermes plc. interest expense for fiscal 2020 was $8.66M, a 36.34% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $5.95M 10-Q · filed 2024-07-24 | $11.93M 10-Q · filed 2024-07-24 | $17.98M derived: sum of 3 quarters · filed 2024-07-24 | $23.99M derived: sum of 4 quarters · filed 2024-07-24 |
| 2024-03-31 | $5.98M 10-Q · filed 2024-05-01 | $12.03M derived: sum of 2 quarters · filed 2024-05-01 | $18.04M derived: sum of 3 quarters · filed 2024-05-01 | $23.72M derived: sum of 4 quarters · filed 2024-07-24 |
| 2023-12-31 | $6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $12.06M derived: sum of 2 quarters · filed 2024-02-21 | $17.74M derived: sum of 3 quarters · filed 2024-07-24 | $23.03M 10-K · filed 2024-02-21 |
| 2023-09-30 | $6.01M 10-Q · filed 2023-10-25 | $11.69M derived: sum of 2 quarters · filed 2024-07-24 | $16.98M 10-Q · filed 2023-10-25 | $21.75M derived: sum of 4 quarters · filed 2024-07-24 |
| 2023-06-30 | $5.68M 10-Q · filed 2024-07-24 | $10.97M 10-Q · filed 2024-07-24 | $15.74M derived: sum of 3 quarters · filed 2024-07-24 | $19.29M derived: sum of 4 quarters · filed 2024-07-24 |
| 2023-03-31 | $5.29M 10-Q · filed 2024-05-01 | $10.06M derived: sum of 2 quarters · filed 2024-05-01 | $13.61M derived: sum of 3 quarters · filed 2024-05-01 | $15.98M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $8.32M derived: sum of 2 quarters · filed 2024-02-21 | $10.69M derived: sum of 3 quarters · filed 2024-02-21 | $13.04M 10-K · filed 2024-02-21 |
| 2022-09-30 | $3.55M 10-Q · filed 2023-10-25 | $5.92M derived: sum of 2 quarters · filed 2023-10-25 | $8.27M 10-Q · filed 2023-10-25 | $10.68M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $2.37M 10-Q · filed 2023-07-26 | $4.72M 10-Q · filed 2023-07-26 | $7.12M derived: sum of 3 quarters · filed 2024-02-21 | $9.56M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $2.35M 10-Q · filed 2023-04-26 | $4.75M derived: sum of 2 quarters · filed 2024-02-21 | $7.19M derived: sum of 3 quarters · filed 2024-02-21 | $9.60M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $4.84M derived: sum of 2 quarters · filed 2024-02-21 | $7.25M derived: sum of 3 quarters · filed 2024-02-21 | $11.22M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.44M 10-Q · filed 2022-11-02 | $4.84M derived: sum of 2 quarters · filed 2022-11-02 | $8.81M 10-Q · filed 2022-11-02 | $10.68M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.41M 10-Q · filed 2022-07-27 | $6.38M 10-Q · filed 2022-07-27 | $8.25M derived: sum of 3 quarters · filed 2023-02-16 | $10.06M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $3.97M 10-Q · filed 2022-04-27 | $5.84M derived: sum of 2 quarters · filed 2023-02-16 | $7.65M derived: sum of 3 quarters · filed 2023-02-16 | $9.77M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $3.68M derived: sum of 2 quarters · filed 2023-02-16 | $5.80M derived: sum of 3 quarters · filed 2023-02-16 | $8.66M 10-K · filed 2023-02-16 |
| 2020-09-30 | $1.81M 10-Q · filed 2021-10-27 | $3.93M derived: sum of 2 quarters · filed 2021-10-27 | $6.79M 10-Q · filed 2021-10-27 | $9.99M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $2.12M 10-Q · filed 2021-07-28 | $4.98M 10-Q · filed 2021-07-28 | $8.18M derived: sum of 3 quarters · filed 2022-02-16 | $11.56M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $2.86M 10-Q · filed 2021-04-28 | $6.05M derived: sum of 2 quarters · filed 2022-02-16 | $9.44M derived: sum of 3 quarters · filed 2022-02-16 | $12.96M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $6.58M derived: sum of 2 quarters · filed 2022-02-16 | $10.10M derived: sum of 3 quarters · filed 2022-02-16 | $13.60M 10-K · filed 2022-02-16 |
| 2019-09-30 | $3.38M 10-Q · filed 2020-10-29 | $6.91M derived: sum of 2 quarters · filed 2020-10-29 | $10.40M 10-Q · filed 2020-10-29 | $13.88M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $3.52M 10-Q · filed 2020-07-29 | $7.02M 10-Q · filed 2020-07-29 | $10.50M derived: sum of 3 quarters · filed 2021-02-11 | $13.84M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $3.50M 10-Q · filed 2020-04-29 | $6.98M derived: sum of 2 quarters · filed 2021-02-11 | $10.32M derived: sum of 3 quarters · filed 2021-02-11 | $13.45M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $6.82M derived: sum of 2 quarters · filed 2021-02-11 | $9.95M derived: sum of 3 quarters · filed 2021-02-11 | $15.44M 10-K · filed 2021-02-11 |
| 2018-09-30 | $3.35M 10-Q · filed 2019-10-23 | $6.47M derived: sum of 2 quarters · filed 2019-10-23 | $11.96M 10-Q · filed 2019-10-23 | $15.15M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $3.13M 10-Q · filed 2019-07-25 | $8.61M 10-Q · filed 2019-07-25 | $11.80M derived: sum of 3 quarters · filed 2020-02-13 | $14.93M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $5.49M 10-Q · filed 2019-04-25 | $8.68M derived: sum of 2 quarters · filed 2020-02-13 | $11.81M derived: sum of 3 quarters · filed 2020-02-13 | $14.73M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $6.32M derived: sum of 2 quarters · filed 2020-02-13 | $9.24M derived: sum of 3 quarters · filed 2020-02-13 | $12.01M 10-K · filed 2020-02-13 |
| 2017-09-30 | $3.13M 10-Q · filed 2018-10-23 | $6.05M derived: sum of 2 quarters · filed 2018-10-23 | $8.82M 10-Q · filed 2018-10-23 | $13.71M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $2.92M 10-Q · filed 2018-07-26 | $5.69M 10-Q · filed 2018-07-26 | $10.58M derived: sum of 3 quarters · filed 2019-02-15 | $13.96M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $2.76M 10-Q · filed 2018-04-26 | $7.66M derived: sum of 2 quarters · filed 2019-02-15 | $11.04M derived: sum of 3 quarters · filed 2019-02-15 | $14.36M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $8.27M derived: sum of 2 quarters · filed 2019-02-15 | $11.59M derived: sum of 3 quarters · filed 2019-02-15 | $14.89M 10-K · filed 2019-02-15 |
| 2016-09-30 | $3.38M 10-Q · filed 2017-10-26 | $6.70M derived: sum of 2 quarters · filed 2017-10-26 | $9.99M 10-Q · filed 2017-10-26 | $13.31M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $3.32M 10-Q · filed 2017-07-27 | $6.62M 10-Q · filed 2017-07-27 | $9.94M derived: sum of 3 quarters · filed 2018-02-16 | $13.26M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $3.29M 10-Q · filed 2017-04-27 | $6.61M derived: sum of 2 quarters · filed 2018-02-16 | $9.94M derived: sum of 3 quarters · filed 2018-02-16 | $13.25M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $6.64M derived: sum of 2 quarters · filed 2018-02-16 | $9.96M derived: sum of 3 quarters · filed 2018-02-16 | $13.25M 10-K · filed 2018-02-16 |
| 2015-09-30 | $3.33M 10-Q · filed 2016-11-02 | $6.64M derived: sum of 2 quarters · filed 2016-11-02 | $9.93M 10-Q · filed 2016-11-02 | $13.26M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $3.31M 10-Q · filed 2016-07-28 | $6.60M 10-Q · filed 2016-07-28 | $9.94M derived: sum of 3 quarters · filed 2017-02-17 | $13.29M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $3.29M 10-Q · filed 2016-04-28 | $6.62M derived: sum of 2 quarters · filed 2017-02-17 | $9.98M derived: sum of 3 quarters · filed 2017-02-17 | $13.36M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $6.69M derived: sum of 2 quarters · filed 2017-02-17 | $10.07M derived: sum of 3 quarters · filed 2017-02-17 | $13.43M 10-K · filed 2017-02-17 |
| 2014-09-30 | $3.36M 10-Q · filed 2015-10-29 | $6.74M derived: sum of 2 quarters · filed 2015-10-29 | $10.10M 10-Q · filed 2015-10-29 | $13.53M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $3.38M 10-Q · filed 2015-07-30 | $6.74M 10-Q · filed 2015-07-30 | $10.18M derived: sum of 3 quarters · filed 2016-02-25 | $13.65M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $3.36M 10-Q · filed 2015-04-30 | $6.79M derived: sum of 2 quarters · filed 2016-02-25 | $10.27M derived: sum of 3 quarters · filed 2016-02-25 | $13.73M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $3.43M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $6.91M derived: sum of 2 quarters · filed 2016-02-25 | $10.38M 10-K · filed 2016-02-25 | $21.85M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-09-30 | $3.48M 10-Q · filed 2014-10-29 | $6.95M 10-Q · filed 2013-10-31 | $18.42M 10-Q · filed 2014-10-29 | $23.12M derived: sum of 4 quarters · filed 2014-10-29 |
| 2013-06-30 | $3.47M 10-Q · filed 2014-07-31 | $14.94M 10-Q · filed 2014-07-31 | $19.64M derived: sum of 3 quarters · filed 2014-07-31 | $42.29M derived: sum of 4 quarters · filed 2014-07-31 |
| 2013-03-31 | $11.47M 10-Q · filed 2014-04-30 | $16.18M derived: sum of 2 quarters · filed 2014-04-30 | $38.82M derived: sum of 3 quarters · filed 2014-04-30 | $48.99M 10-K · filed 2015-02-24 |
| 2012-12-31 | $4.70M 10-Q · filed 2013-01-31 | $27.35M derived: sum of 2 quarters · filed 2013-10-31 | $37.52M 10-Q · filed 2013-01-31 | $47.61M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-09-30 | $22.65M 10-Q · filed 2013-10-31 | $32.82M 10-Q · filed 2013-10-31 | $42.91M derived: sum of 3 quarters · filed 2014-02-27 | $53.37M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $10.17M 10-Q · filed 2013-07-25 | $20.26M derived: sum of 2 quarters · filed 2014-02-27 | $30.72M derived: sum of 3 quarters · filed 2014-02-27 | $38.28M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $10.09M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $20.55M derived: sum of 2 quarters · filed 2014-02-27 | $28.11M derived: sum of 3 quarters · filed 2014-02-27 | $28.11M 10-KT · filed 2014-02-27 |
| 2011-12-31 | $10.46M 10-Q · filed 2013-01-31 | $18.02M derived: sum of 2 quarters · filed 2013-01-31 | $18.02M 10-Q · filed 2013-01-31 | |
| 2011-09-30 | $7.56M 10-Q · filed 2012-11-01 | $7.56M 10-Q · filed 2012-11-01 | ||
| 2011-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23 | $0.00 derived: sum of 2 quarters · filed 2013-05-23 | $2.17M derived: sum of 3 quarters · filed 2013-05-23 | $3.30M 10-K · filed 2013-05-23 |
| 2010-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | $2.17M derived: sum of 2 quarters · filed 2012-02-02 | $3.30M 10-Q · filed 2012-02-02 | |
| 2010-09-30 | $2.17M 10-Q · filed 2011-11-03 | $3.30M 10-Q · filed 2011-11-03 | ||
| 2010-03-31 | $5.97M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |